Skip to Content

93 7327 (Trandolapril 4 mg)

Pill with imprint 93 7327 is Pink, Elliptical / Oval and has been identified as Trandolapril 4 mg. It is supplied by Teva Pharmaceuticals USA.

Trandolapril is used in the treatment of diabetic kidney disease; heart attack; heart failure; high blood pressure; left ventricular dysfunction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Trandolapril 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7327

Trandolapril 4 mg 93 7327
Trandolapril 4 mg 93 7327 Front
Trandolapril 4 mg 93 7327 Back
Trandolapril 4 mg 93 7327
Trandolapril 4 mg 93 7327
Trandolapril 4 mg 93 7327

Trandolapril

Imprint
93 7327
Strength
4 mg
Color
Pink
Size
11.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Angiotensin converting enzyme inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
ferric oxide yellow, lactose anhydrous, povidone k30, corn starch, sodium stearyl fumarate, ferric oxide red

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7327 Teva Pharmaceuticals USA, Inc.
42291-0839 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.